Marshall Wace, LLP Brainsway Ltd. Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
A detailed history of Marshall Wace, LLP transactions in Brainsway Ltd. stock. As of the latest transaction made, Marshall Wace, LLP holds 84,926 shares of BWAY stock, worth $784,716. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,926
Previous 147,909
42.58%
Holding current value
$784,716
Previous $782,000
34.14%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BWAY
# of Institutions
28Shares Held
3.58MCall Options Held
0Put Options Held
0-
Masters Capital Management LLC Atlanta, GA900KShares$8.32 Million0.31% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L3805KShares$7.44 Million0.08% of portfolio
-
Essex Investment Management CO LLC Boston, MA347KShares$3.21 Million0.42% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA298KShares$2.75 Million0.46% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny277KShares$2.56 Million0.0% of portfolio
About Brainsway Ltd.
- Ticker BWAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,519,200
- Market Cap $153M
- Description
- Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...